With only 12% 1 of therapies surviving the gauntlet of Phase III trials to receive FDA approval, and the cost to bring a drug ...

Expert Systems, a leader in combining human and artificial intelligence to accelerate drug discovery, celebrates a key milestone in the development of ratutrelvir, a SARS-CoV-2 Main protease (Mpro) ...

A new publication in Nature Reviews Methods Primers provides essential guidance for conducting rigorous systematic reviews on ...

A new thought piece led by the Harvard Pilgrim Health Care Institute with collaborators from Duke University and Kaiser Permanente Washington Health Research Institute highlights the challenges facing ...

Phase 2 trial is an adaptive designed randomized study comparing NGC-Cap to monotherapy capecitabineResults from this Phase 2 trial will evaluate ...

The failure of clinical trials using gamma-secretase inhibitors ... the researchers will carry out more research on cellular homeostasis in the early phases of AD and will collaborate with colleagues ...

Car-T cell therapy has changed the face of many cancer treatments, but the level of customization it requires still comes ...

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

Avera participates in numerous clinical trials, including ones that are Phase 1. In this Avera Medical Minute, we share what ...

UCSF officially broke ground on the Barbara and Gerson Bakar Research and Academic Building on Sept. 28, which will house state-of-the-art research facilities, and will also serve as the new home for ...